Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Finance > Structured Settlements > Viatical Settlement - A Win-Win Situation for Most

Tags

  • death
  • which
  • their
  • developing combination
  • developing combination
  • developing combination

  • Links

  • Getting a Job Writing Website Content??”10 SEO Tips for Creating a Sample Web Page
  • How A Virtual Switchboard Lets Home Workers Answer Calls Professionally
  • Walk Your Way To Better Health
  • Top Articles - Viatical Settlement - A Win-Win Situation for Most

    Viaticum is the Eucharist given to a person on the verge of death, or to one who is facing a possibility of death. It is no wonder,
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    then, that this Latin word would be the root of the term – Viatical Settlement.

    Viatical Settlement involves the sale of a life ins
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    rance policy to an investor. A Viatical settlement is usually carried out by the terminally ill – those who face penury by the cost
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    f maintenance alone, those who expect to live not longer than two years. That being said, a Viatical settlement is purely a financia
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    transaction. The viator, the one selling the life insurance, sells the policy at a discounted price of the death benefit of the pol
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    cy and is provided with immediate cash settlement. This usually helps in paying the medical bills of the aged person.

    The investor
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    s the buyer of the policy. The investor has two options. One is to sell the policy to a third-party, or to stash the policy as a com
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    any investment. Viatical settlements are especially attractive to investors and the rates of return, though not guaranteed, are pote
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    tially high. As with any kind of deal, risks are always present for both parties. For the Viator, the primary risk is settling for a
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    low price. Of course, compared to the future premiums, the price would be lower, but there is still the danger of the policy being b
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ught at a song.

    For the investor, the risks are greater. There is the probability that the investor will not receive the full death
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    benefit should unfortunate circumstances cause the insurance company to go bankrupt. There could also be the ghost of a chance that
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    he Viator may have committed fraud upon signing insurance forms. Or the Viator may have a miraculous recovery and go on to live for
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    nother twenty years.

    Viatical settlement should be thought more than twice before being engaged into. This is not a regulated inves
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ment and crooks abound, waiting to pounce on the gullible and the dying. Here are sound advices, both for potential Viators and inve
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    tors:

    For Potential Viators:

    · Check with your insurer to find out if your policy includes Accelerated Death Benefits. This will g
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    t you much more money and you will be paid much faster.

    · If you are a member of a Credit Union, seek information about licensed Vi
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    tical providers.

    · Apply to more than one Viatical settlement company.

    For Potential Investors:

    · Do not use your IRA for Viatica
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    investments. It is prohibited by the Internal Revenue Code.

    · To be safe, do not buy a policy that is within the contestability pe
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    iod. That way, if the viator committed fraud on his application and was discovered, you won’t be left with just a return of premiums


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/118249/toparticles-Viatical-Settlement--A-WinWin-Situation-for-Most.html">Viatical Settlement - A Win-Win Situation for Most</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/118249/toparticles-Viatical-Settlement--A-WinWin-Situation-for-Most.html]Viatical Settlement - A Win-Win Situation for Most[/url]

    Related Articles:

    Hiring Decisions: Don't Settle

    Ten Signs That It is Time to Sell the Family Business

    Enhance Home Value Through Online Home Improvement Loan

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com